Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2003-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-8981(02)00431-XPMID 12589973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterizations of recombinant human tartrate-resistant acid phosphatase from osteosarcoma: comparison study between recombinant and placental proteins.

  2001cited by this paper
• Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.

  2001cited by this paper
• Tartrate‐Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption

  2000cited by this paper
• Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.

  1999cited by this paper
• High Bilirubin Levels Interfere with Serum Tartrate-Resistant Acid Phosphatase Determination: Relevance as a Marker of Bone Resorption in Jaundiced Patients

  1999cited by this paper
• Two‐Site Immunoassays for Osteoclastic Tartrate‐Resistant Acid Phosphatase Based on Characterization of Six Monoclonal Antibodies

  1999cited by this paper
• Characterization of Serum Tartrate‐Resistant Acid Phosphatase and Development of a Direct Two‐Site Immunoassay

  1998cited by this paper
• Tartrate‐resistant acid phosphatase from human bone: Purification and development of an immunoassay

  1996cited by this paper
• Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum.

  1995cited by this paper
• Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.

  1990cited by this paper
• Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta.

  1989cited by this paper
• Ultrastructural localization of tartrate‐resistant, purple acid phosphatase in rat osteoclasts by histochemistry and immunocytochemistry

  1989cited by this paper
• Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase.

  1987cited by this paper
• The rapid appearance of acid phosphatase activity at the developing ruffled border of parathyroid hormone activated medullary bone osteoclasts

  1985cited by this paper
• The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.

  1985cited by this paper
• Tartrate-resistant acid phosphatase in human alveolar macrophages.

  1985cited by this paper
• Uteroferrin and the purple acid phosphatases.

  1983cited by this paper
• Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function

  1982cited by this paper
• Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease.

  1982cited by this paper
• Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.

  1981cited by this paper
• A tartrate-resistant acid phosphatase from Gaucher spleen. Purification and properties.

  1980cited by this paper
• Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children.

  1978cited by this paper
• Clinical significance of the human acid phosphatases: a review.

  1974cited by this paper
• Investigations on acid phosphatase activity in human plasma and serum.

  1973cited by this paper

• A defect-engineered bimetallic MOF nanozyme with enhanced activity for colorimetric detection of acid phosphatase.

  2025cites this paper
• Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase.

  2011cites this paper
• Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats

  2011cites this paper
• Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.

  2010cites this paper
• Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in cell and animal models

  2010cites this paper
• Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.

  2009cites this paper
• Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme

  2009cites this paper
• OSTEOCLASTIC TARTRATE-RESISTANT ACID PHOSPHATASE 5b Diagnostic Use and Biological Significance in Bone Physiology

  2009cites this paper
• Utility of serum tartrate‐resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction

  2008influential citation
• Tartrate-resistant acid phosphatase activity and glutathione levels are modulated during hFOB 1.19 osteoblastic differentiation

  2008cites this paper
• Serum Levels of TRAP5b, a New Bone Resorption Marker Unaffected by Renal Dysfunction, as a Useful Marker of Cortical Bone Loss in Hemodialysis Patients

  2008cites this paper
• Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.

  2008cites this paper
• The evaluation of Tracp5b as a marker for monitoring treatment results of bone metastasis in breast cancer patients

  2008cites this paper
• Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women

  2008cites this paper
• Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.

  2006cites this paper
• Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.

  2005cites this paper
• Perfil de atividade da proteína tirosina fosfatase de baixa massa molecular relativa e da fosfatase ácida resistente ao tartarato em osteoblastos humanos durante o ciclo e diferenciação celular

  2005cites this paper
• Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.

  2005cites this paper
• N-glycosylation influences the latency and catalytic properties of mammalian purple acid phosphatase.

  2005cites this paper
• Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.

  2004cites this paper
• Changes in receptor activator of nuclear factor‐kappaB, and its ligand, osteoprotegerin, bone‐type alkaline phosphatase, and tartrate‐resistant acid phosphatase in ovariectomized rats

  2004cites this paper